Harbinger Health’s Steve Hahn on the science of early cancer Dx after raising a $140M Series B
- blonca9
- Sep 28, 2023
- 1 min read
Steve Hahn describes how Harbinger Health is trying to catch the earliest signals of cancer, and how physicians and patients might use this information.